FISOF yields 852.88% · PFE yields 6.13%● Live data
📍 FISOF pulled ahead of the other in Year 1
Combined, FISOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FISOF + PFE for your $10,000?
Fission 3.0 Corp. engages in the acquisition, exploration, and development of uranium resource properties. The company holds 100% interests in the Clearwater West property that comprises 3 contiguous claims covering 11,786 hectares located in Saskatchewan, Canada; the Patterson Lake North property that consists of 38 claims covering 39,946 hectares situated in Saskatchewan, Canada; the Wales Lake property that comprises 31 claims covering an area of 40,986 hectares located in southwest Athabasca basin; and the Key Lake area portfolio consisting of the Bird Lake, Grey Island, Hobo Lake, Lazy Edward Bay, and Seahorse Lake properties, which comprise 81 claims and 57,131 hectares located in Saskatchewan, Canada. It also has 100% interests in the Beaverlodge/uranium city area portfolio that consists of 50 claims and 41,537 hectares located in Saskatchewan, Canada; and the northeast Athabasca basin area, which comprise 36 claims covering an area of 21,059 hectares situated in Saskatchewan, Canada. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.
Full FISOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.